Bank of America
ALLR

Bank of America’s Allarity Therapeutics ALLR Stock Holding History

Bank of America’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-140
Closed -$151 – 5735
2025
Q4 		$151 Buy
140
+6
+4% +$8 ﹤0.01% 6749
2025
Q3 		$212 Sell
134
-4
-3% -$5 ﹤0.01% 7722
2025
Q2 		$139 Buy
138
+100
+263% +$95 ﹤0.01% 7912
2025
Q1 		$36 Buy
38
+16
+73% +$17 ﹤0.01% 8031
2024
Q4 		$26 Buy
22
+11
+100% +$15 ﹤0.01% 7980
2024
Q3 		$23 Buy
11
+6
+120% +$28 ﹤0.01% 7952
2024
Q2 		$31 Buy
+5
New +$196 ﹤0.01% 7925
2023
Q2 		– Hold
0
– -$32 – 7688
2023
Q1 		– Hold
0
– – – 7541
2022
Q4 		– Hold
0
– – – 7554
2022
Q3 		– Hold
0
– – – 7644
2022
Q2 		– Hold
0
– – – 7756
2022
Q1 		– Hold
0
– – – 7966

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of America's ALLR Position: Q1 2026 in Review

Bank of America sold out of Allarity Therapeutics (ALLR) in Q1 2026, closing a stake of 140 shares — an estimated $151 sold.

Bank of America first reported a position in ALLR in Q2 2024 and held it in 7 quarters. The position peaked at $212 in Q3 2025. 14 funds tracked by Wall St. Rank hold ALLR as of Q1 2026.

  • Bank of America reported no remaining Allarity Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 140 Allarity Therapeutics shares in Q1 2026, an estimated $151.
  • Bank of America first reported a position in Allarity Therapeutics in Q2 2024 and held it in 7 quarters.
  • Bank of America's Allarity Therapeutics position peaked at $212 in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.